BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events
X-WR-CALDESC:Events for 
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231025T090000
DTEND;TZID=America/New_York:20231025T130000
DTSTAMP:20260417T123627
CREATED:20230921T154309Z
LAST-MODIFIED:20230921T154309Z
UID:4010-1698224400-1698238800@www.mdtechcouncil.com
SUMMARY:Harnessing the Potential of Antibody Drug Conjugates in Oncology
DESCRIPTION:Join us for Harnessing the Potential of Antibody Drug Conjugates (ADCs) in Oncology\, on October 25 at Johnson & Johnson Innovation – JLABS @ Washington\, DC. We’ll host industry thought leaders  as they dig deeper on how ADCs have become a promising cancer treatment and key component in the next generation of oncology therapeutics. \nDubbed ‘the next pillar of cancer therapeutics’\, ADC technology delivers highly potent treatment agents to specific tumor cells connected to malignancy. From 2019 – 2022\, 8 ADCs received FDA approval and dozens more investigational treatments flooded the industry pipeline. Our program will explore the resurgence around their potential in oncology\, showcasing innovation in ADC development\, exploring the current science and regulatory landscape for oncology\, and highlighting investors’ perspectives as breakthrough research that requires support pours in. \nAfter the programming concludes\, there will be an opportunity to participate in partnering meetings to connect one-on-one with industry leaders in this space.  All individuals (startups\, oncology companies\, academics and researchers\, industry partners) interested in being considered for an opportunity for one-on-one partnering will need to apply by Friday\, October 6th. Selected companies will be notified of their acceptance on Wednesday\, October 18th. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/harnessing-the-potential-of-antibody-drug-conjugates-in-oncology/
LOCATION:Johnson & Johnson Innovation – JLABS @ Washington\, DC\, 7144 13th Pl NW\, Suite 2200\, Washington\, DC\, 20012\, United States
GEO:38.976951;-77.0325182
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Johnson & Johnson Innovation – JLABS @ Washington DC 7144 13th Pl NW Suite 2200 Washington DC 20012 United States;X-APPLE-RADIUS=500;X-TITLE=7144 13th Pl NW\, Suite 2200:geo:-77.0325182,38.976951
END:VEVENT
END:VCALENDAR